PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Hydroxychloroquine 22mg/5ml oral solution
1001030C0AAAUAU
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 250mg/5ml oral solution
1001030C0AABEBE
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 25mg/5ml oral solution
1001030C0AAASAS
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 30mg/5ml oral solution
1001030C0AAAMAM
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 36mg/5ml oral solution
1001030C0AABFBF
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 400mg/5ml oral solution
1001030C0AAAWAW
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 400mg/5ml oral suspension
1001030C0AABLBL
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 40mg/5ml oral solution
1001030C0AAAHAH
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 53.33mg/5ml oral solution
1001030C0AABDBD
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 60mg/5ml oral solution
1001030C0AAALAL
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 65mg/5ml oral solution
1001030C0AAAQAQ
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 70mg/5ml oral solution
1001030C0AAAZAZ
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 75mg/5ml oral liquid
1001030C0AAAGAG
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 80mg/5ml oral solution
1001030C0AABHBH
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxychloroquine 85mg/5ml oral solution
1001030C0AAAYAY
Hydroxychloroquine sulfate Hydroxychloroquine sulfate Musculoskeletal and Joint Diseases No data available
Hydroxyethyl salicylate 6% / Methyl nicotinate 1.6% spray
1003020N0AAAZAZ
Methyl salicylate Methyl salicylate Musculoskeletal and Joint Diseases No data available
Hyrimoz 40mg/0.4ml inj pre-filled syringes
1001030S0BEADAE
Hyrimoz Adalimumab Musculoskeletal and Joint Diseases No data available
Hyrimoz 40mg/0.4ml solution for injection pre-filled pens
1001030S0BEACAD
Hyrimoz Adalimumab Musculoskeletal and Joint Diseases No data available
Hyrimoz 40mg/0.8ml inj pre-filled syringes
1001030S0BEABAA
Hyrimoz Adalimumab Musculoskeletal and Joint Diseases No data available
Ibucalm Ibuprofen Pain Relief 5% gel
1003020P0BUAAAC
Ibucalm (Topical Ibuprofen) Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibuderm 5% gel
1003020P0BTAAAC
Ibuderm Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibufem 200mg tablets
1001010J0CHAAAD
Ibufem Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibular 200mg tablets
1001010J0DJAAAD
Ibular (Ennogen) Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibular 400mg tablets
1001010J0DJABAE
Ibular (Ennogen) Ibuprofen Musculoskeletal and Joint Diseases No data available
Ibuleve 5% Mousse
1003020P0BCAEAF
Ibuleve Ibuprofen Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.